Join us as leading experts discuss key data and perspectives from the late-breaking sessions at this year’s AAD meeting This March, experts from around the world gathered in Denver, Colorado, for the 2026 American Academy of Dermatology (AAD) Annual Meeting. ...

Founded by internationally recognised experts the IDS meeting brings together world leaders working across immune-activated skin conditions such as psoriasis, atopic dermatitis, alopecia areata, vitiligo and hidradenitis suppurativa. To capture key perspectives from the 2025 Summit, we spoke with editorial board member, Prof. Dedee Murrell, to bring you some of the key highlights from a selection of standout presentations delivered during the three-day event.

Editors-in-Chief Professor Tiago Torres and Dr Raj Chovatiy, will lead touchREVIEWS in Dermatology, our platform's forthcoming free-to-access, peer-reviewed journal. Committed to improving patient outcomes, the journal aims to support healthcare professionals and researchers worldwide in the continuous development of their knowledge and confidence to enhance patient care, drive meaningful change in clinical practice, and promote equity in healthcare globally.

As the field of dermatology continues to evolve at pace, the questions shaping its future are no longer confined to new drugs or devices. Looking ahead, we asked our Future Leaders of 2025 a question: which emerging trend or topic deserves greater attention in 2026? Their responses collectively offer a snapshot of the conversations poised to shape the specialty in the year ahead, highlighting challenges that extend beyond scientific innovation alone.

SPINK5-sEDD, a syndromic epidermal differentiation disorder formerly known as Netherton syndrome, is the focus of this latest instalment in our rare disease round-up series, which highlights advances in diagnosing and managing uncommon dermatological conditions. In this Q&A, Dr Pablo López Balboa – a paediatric dermatologist specialising in complex and rare skin diseases – discusses the evolving understanding of SPINK5-sEDD, from its characteristic clinical triad and neonatal presentation to the underlying protease-driven pathology and emerging therapeutic strategies.

Laser and energy based devices are transforming dermatology, offering increasingly advanced ways to treat a wide range of conditions from pigment disorders and tattoo removal to skin rejuvenation and aesthetic enhancement. As the technology evolves, so too does our understanding of how to use it most effectively in clinical practice. At the same time, the field faces significant challenges, including the influence of marketing and the importance of selecting these technologies appropriately.

The FDA recently approved roflumilast 0.3% foam for the treatment of plaque psoriasis of the scalp and body in both adolescents and adults. To better understand how this newly approved therapy fits into clinical practice, what the data show and which patients are likely to benefit, we spoke with Dr Jennifer Soung (Harbor University of California, Los Angeles and Southern California Dermatology, Santa Ana, CA, USA), a key investigator on the phase 3 ARRECTOR trial.

The International Society of Dermatology (ISD) stands at the forefront of advancing global skin health through education, collaboration and outreach.1 Established with a mission to bridge disparities in dermatological care worldwide, the ISD has become a vital hub for connecting ...

Pyoderma gangrenosum (PG) is a rare, painful and complex autoimmune skin condition that can present significant diagnostic and treatment challenges.1   To provide expert insights into this challenging disease, we spoke with Dr Benjamin Kaffenberger, a dermatologist at The Ohio State ...